Health

Pfizer, BioNTech plan filing as vaccine reflect 95% effectivity

Haryana Minister Anil Vij volunteers for COVAXIN Phase 3 trial

YouTube to add link on COVID-19 vaccines to curb spread of misinformation

Pfizer on the verge to apply COVID-19 vaccine for emergency use authorization

US FDA approves 1st COVID-19 home-testing kit, gives results withing 30 minutes

Cipla signs licensing agreement with Multi G

Cipla Limited on Wednesday announced that it has signed a licensing agreement with Belgium-based firm, Multi G for the distribution of their COVID-19 Rapid Antibody test kit, across Emerging markets and Europe.

After halting clinical trials, Brazil to receive first dose of China’s Sinovac vaccine this week

Pfizer to start its ‘first ever COVID-19 vaccine delivery program’ in four US states

Bharat Biotech to commence Phase 3 trail of COVAXIN with 26,0000 participants

Moderna reports preliminary trial data: COVID-19 vaccine is more than 94% effective

COVID-19 Vaccine: First batch of Russian candidate Sputnik-V to reach Kanpur for Phase 2 & 3 trials

. College principal R B Kamal confirmed that the human clinical trials of the vaccine begin next week.

Are people scared of using the COVID-19 vaccine?

India to get 100 million shots of AstraZeneca COVID-19 vaccine ‘AZD1222’ by next month

WHO announces plans to set up traditional medicine centres in India

India to get 200 million doses of AstraZeneca vaccine by January

Aurobindo Pharma ready to manufacture COVID-19 vaccines for others